CXM 510(k) approval getting close

I have been watching CXM for over a year now and watched it go from $2.25 to .30. It has been a true roller coaster ride. I do believe that the ride to the top may be coming soon. CXM is getting their packaging together for their Excellagen product for final FDA approval. The packaging is scheduled to be completed by the end of September, 2010, and then presented to the FDA. If accepted FDA 510(k) approval could be given soon after. I suspect, knowing how the government works it could be 1 to 3 months, but hopefully before the end of the year. CXM closed Friday at .44. As September comes to a close and the company posts favorable news on the packaging, I expect to see CXM move slowly upward toward .60. Then if the FDA approval comes through, who knows what will happen. I suggest reading the recent articles put out by CXM at their website. The Excellagen product for the treatment of diabetic wounds that is up for FDA approval was a by-product of their MATRIX Phase 2b Excellarate Clinical Study conducted last year. Go to their website and read about it. website is cardiumthx.com. I suggest buying while the stock is still a bargain. I am betting on this company to come through before the end of the year. They have several other great products coming on line next year. I am with CXM for the long haul. GL to all.